Clinical Trials
12 trialsNCT05006196 2026-05-20
IMOGEN
Perspectum
Active not recruiting
NCT05755269 2026-05-01
Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women
Mayo Clinic
Terminated
NCT07432308 2026-03-06
Liquid biopsy
Institute of Oncology Ljubljana
Phase NA Completed
NCT02404584 2025-12-04
GenCInibs-Suni
Centre Hospitalier Universitaire de NÄ«mes
Completed
NCT05120284 2025-08-29
Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)
University of Florida
Phase 2 Active not recruiting
NCT06534424 2025-06-27
Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT05766098 2024-10-08
PTC-ARRAY
Istituto Auxologico Italiano
Recruiting
NCT05876728 2023-05-25
Role of Irisin/FNDC5 (rs3480) Single Nucleotide Polymorphism in Breast Cancer
Sohag University
Unknown
NCT05539274 2022-10-03
Cervical Carcinoma in Shatby University Hospital and Its Relation to Human Papilloma Virus
Alexandria University
Completed
NCT05380128 2022-05-18
Association Study Between VDR Gene Polymorphisms and Risk and Features of MG in Han Chinese Population
Beijing Tongren Hospital
Completed
NCT05329597 2022-04-15
Study on Umorestat Hydrogen Sulfate Capsule in Patients With Locally Advanced/Metastatic Pancreatic Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Unknown
NCT00580021 2016-01-28
Clinical Outcomes in Hereditary Cancer
Memorial Sloan Kettering Cancer Center
Withdrawn